Hip Replacement Risk of Death: What to Know

Elective hip replacement is one of the safest major surgeries performed today, with a 30-day mortality rate of roughly half a percent across all age groups in recent studies. That figure drops considerably for younger, healthier patients getting a planned procedure for arthritis. But the picture changes dramatically when the surgery is done on an emergency basis after a hip fracture, where mortality can be several times higher. Understanding the difference between these two scenarios, and the specific factors that raise or lower risk, is the most useful thing you can take away from the research.

How Low Is the Risk for a Planned Hip Replacement

A meta-analysis covering studies from 2011 to 2021 found the 30-day mortality rate following total hip replacement was about 0.49%.¹ That includes all patients, of all ages and health levels, some of whom had serious medical conditions going into surgery. For context, that means roughly one in 200 patients does not survive the first month. And that meta-analysis pools many different patient populations, so the actual number for someone in their 60s with well-controlled health conditions is lower still.

Age is the single biggest divider. In a large database study, the 30-day death rate per 1,000 patients was essentially zero for people under 40, climbed to about 0.07% for those in their 60s, 0.13% for those in their 70s, and 0.35% for people aged 80 to 89.² Even at the oldest end, this means roughly three or four deaths per thousand procedures, a number that puts elective hip replacement among the safer operations in all of surgery for its complexity.

Why Hip Fracture Surgery Carries a Much Higher Risk

When people hear frightening statistics about hip replacement mortality, they are often looking at numbers from hip fracture surgery, which is a fundamentally different situation. A large study comparing more than 300,000 hip fracture operations against elective hip replacements found that in-hospital death after fracture surgery was about 3.4%, compared with 0.18% for elective procedures. After adjusting to match similar patients, hip fracture surgery still carried nearly six times the mortality risk.³

The reasons are straightforward. Fracture patients arrive in the emergency room in pain, often dehydrated, sometimes with heart problems or pneumonia already developing. They are typically older and frailer than people who walk into a planned surgery. They have not had weeks of optimization, no time to manage blood pressure or blood sugar, no chance to stop blood thinners. The surgery itself may also differ, since fractures sometimes require more complex fixation. Major complications after fracture surgery ran about 5.9%, more than double the 2.3% rate seen with elective replacements in that same study.³

Timing matters, too. In a study of over 27,000 matched hip fracture patients, those who waited more than 24 hours for surgery had a 30-day death rate of 6.5% compared with 5.8% for those operated on within 24 hours. Rates of blood clots, heart attacks, and pneumonia were all higher in the delayed group.⁴ A separate study found that delays beyond six days carried an especially pronounced effect on patients who were already medically unwell.⁵

What Actually Causes Deaths After Hip Replacement

Blood clots traveling to the lungs used to be the most feared complication. That has changed. A systematic review found that cardiovascular complications have overtaken fatal pulmonary emboli as the leading cause of death after hip replacement.⁶ In a study of deaths within 90 days of primary hip replacement, ischemic heart disease accounted for about 29% of all fatalities.⁷

The shift away from fatal blood clots is largely a success story. Routine use of blood-thinning medications after surgery has driven the rate of fatal pulmonary embolism down to about 0.07% in one series of over 4,000 patients.⁸ That same study concluded that elective hip and knee replacement should no longer be considered high-risk procedures for fatal clots. Still, symptomatic blood clots remain something to watch for. The overall rate of venous thromboembolism requiring hospitalization within 90 days was about 1% in a large registry study of nearly 68,000 procedures, with most events occurring around three weeks after surgery.⁹

Heart attacks and cardiac arrest together affect about one in 300 hip and knee replacement patients within 30 days, with about 79% of those cardiac events occurring within the first week.¹⁰ People over 80, those taking blood pressure medications, and those with a history of heart disease were at the highest risk. Infection is another potential pathway to death. Patients who developed sepsis after joint replacement had a mortality rate of about 3.7%, compared with 0.1% in those who did not.¹¹

Who Faces the Highest Risk

The research consistently identifies the same cluster of risk factors: advanced age, serious preexisting medical conditions, male sex, and emergency rather than elective admission.¹² Among these, the burden of other medical problems is arguably more predictive than age alone. Patients with a high comorbidity score had roughly nine times the risk of dying within 90 days compared to those with few health problems, even after adjusting for age.³

In practical terms, a 75-year-old with well-controlled blood pressure and no other significant health issues is likely at much lower risk than a 65-year-old with diabetes, heart failure, and kidney disease. The reason surgeons spend so much time reviewing your medical history before scheduling an elective hip replacement is precisely this: they are assessing how much physiological reserve you have to get through the stress of surgery and anesthesia.

Patients undergoing surgery for diagnoses other than osteoarthritis, such as inflammatory arthritis or fractures, also tend to have higher mortality, partly because these conditions themselves carry additional medical complexity.²

How Mortality Has Dropped Over the Decades

Hip replacement has become steadily safer despite being performed on older and sicker patients. A study of U.S. data found that the number of procedures grew by 158% over the study period, while in-hospital mortality actually dipped slightly, from about 0.32% to 0.29%. Average hospital stays dropped from nearly nine days to about four and a half.¹³ A nationwide Danish cohort study found that 60-day mortality after elective hip replacement fell by roughly 60% between the early 1990s and the mid-2000s, a decline that far outpaced improvements in the general population’s survival over the same period. The biggest drops were in deaths from heart attacks, blood clots, pneumonia, and stroke.¹⁴

Better blood-thinning protocols, improved anesthesia monitoring, faster mobilization after surgery, and shorter hospital stays have all contributed. The trend line matters for anyone reading older statistics and worrying: data from the 1990s or early 2000s paints a gloomier picture than current practice warrants.

Does the Hospital or Surgeon Matter

Yes, and the differences are not trivial. A study of U.S. hospitals found that in-hospital mortality for primary hip replacement was 0.16% at the highest-volume hospitals compared with 0.29% at the lowest-volume ones. For revision hip surgery, the gap was even wider: 0.48% at high-volume hospitals versus 1.20% at low-volume ones.¹⁵ A study using Medicare data showed a similar pattern, with patients at hospitals doing more than 100 hip replacements per year having roughly half the mortality rate of patients at hospitals doing 10 or fewer.¹⁶

Surgeon volume matters separately from hospital volume. For revision hip replacements, patients of surgeons who performed more than 10 revisions per year had about half the death rate of those treated by surgeons doing three or fewer per year.¹⁶ This makes intuitive sense: teams that do hundreds of these a year develop smoother systems, catch problems earlier, and have better-rehearsed responses when things go wrong. If you have a choice in where you get your surgery, asking about the hospital’s annual joint replacement volume is a reasonable question.

Anesthesia Choices and What the Evidence Shows

Whether you get spinal anesthesia (a needle in the lower back that numbs you from the waist down) or general anesthesia (being put fully to sleep) has been debated for years. A large retrospective study found that general anesthesia was associated with roughly 28% higher odds of death within 30 days compared with spinal anesthesia for hip fracture surgery.¹⁷ A matched study of elective hip and knee replacements found an even more dramatic difference, with 30-day mortality of 0.19% under spinal versus 0.80% under general anesthesia.¹⁸

However, a rigorous randomized trial in older adults undergoing hip fracture surgery found essentially no difference in 60-day mortality between the two anesthesia types, with rates of about 3.9% and 4.1%.¹⁹ The discrepancy likely reflects the fact that retrospective studies struggle to fully account for why a patient received one type of anesthesia over the other. Sicker patients sometimes need general anesthesia, which inflates its apparent risk. The randomized trial is more trustworthy on the direct comparison, and it suggests the choice of anesthesia type may matter less than the overall quality of anesthetic care.

Long-Term Survival After Hip Replacement

One of the more reassuring findings in the literature is that people who survive the first few months after an elective hip replacement tend to live longer than similar people who did not have the surgery. In a study comparing hip replacement patients against matched controls, the replacement group had a brief spike in mortality right around the time of surgery but, by three months out, their death rate had dropped to about two-thirds of the control group’s rate. That survival advantage persisted for roughly five years before the two groups began to converge.²⁰

A Finnish study found that 10-year survival among hip replacement patients was actually better than the general population’s, at 78% versus 73% for people over 65.²¹ This doesn’t mean the surgery itself extends life. More plausibly, a successful hip replacement restores mobility, which lets people exercise, maintain independence, and avoid the decline that follows immobility. People selected for elective surgery also tend to be healthy enough to be surgical candidates, which introduces a selection effect.

Younger patients (under 45 at the time of surgery) had mortality rates somewhat higher than the general population of the same age, likely because the conditions that lead to a hip replacement in a young person, such as inflammatory disease or avascular necrosis, carry their own health consequences.²²

Infection and Its Outsized Effect on Long-Term Mortality

Joint infection is uncommon but disproportionately dangerous. In a study of patients who developed a periprosthetic joint infection within the first year after their hip replacement, the 10-year mortality rate was about 11.4%, compared with just 2.2% in matched patients without infection. That is roughly a fivefold increase in the hazard of death over the following decade.²³ The connection involves repeated surgeries, prolonged antibiotics, and the systemic toll of chronic infection. This is one reason surgeons are so aggressive about infection prevention, from operating room airflow to pre-surgical skin preparation.

Outpatient Hip Replacement

Same-day or next-day discharge after hip replacement has become increasingly common for carefully selected patients. A propensity-matched analysis of over 574,000 procedures found that outpatient hip replacement had a lower overall rate of adverse events (about 5% versus 10%) compared with inpatient stays, with no increase in 30-day readmission rates.²⁴ A smaller matched-cohort study found similar complication rates between outpatient and inpatient groups, with no serious adverse events in either.²⁵

These numbers carry a caveat: outpatient candidates are cherry-picked. They tend to be younger, healthier, and have strong home support. You cannot compare their outcomes to the general hip replacement population and conclude that shorter stays are inherently safer. What the data does show is that for the right patient, going home the same day does not appear to add risk.

What You Can Do Before Surgery

Preoperative optimization, the process of getting your body into the best possible shape before elective surgery, has measurable effects. A large U.S. healthcare system study found that after implementing a structured optimization program, rates of emergency visits, readmissions, blood clots, revisions, and mortality all dropped among total joint replacement patients.²⁶ The modifiable risk factors that programs typically target include uncontrolled diabetes, anemia, tobacco use, obesity, poor nutrition, untreated heart or lung conditions, and deconditioning.²⁷

Controlling blood sugar in the months before surgery, treating anemia so you go in with better oxygen-carrying capacity, quitting smoking to improve wound healing and lung function, and building leg strength through even modest exercise all shift the odds in your favor. This is the area where you have the most personal control over your surgical risk.

Blood loss during surgery can also affect outcomes. Tranexamic acid, a medication that helps blood clot, has become standard practice. A meta-analysis found that oral tranexamic acid effectively reduced blood loss, the drop in hemoglobin, and the need for transfusions during hip replacement without increasing complications.²⁸

Socioeconomic Factors and Disparities

Mortality after hip replacement is not evenly distributed across society. A Swedish registry study found that patients with higher incomes had roughly half the 30-day mortality risk of those with lower incomes after adjusting for other factors.²⁹ A Danish study found that patients living alone had about 40% higher 90-day mortality than those who lived with someone, and that low education, income, and financial assets were all independently associated with higher death rates within a year.³⁰

A U.S. database analysis of over two million hip replacements found that in-hospital mortality was under 0.2% overall, but that lower-income groups had elevated odds of death, largely because of worse baseline health.³¹ The mechanism is not hard to imagine: people with fewer resources tend to have less access to preventive care, arrive at surgery with more uncontrolled chronic conditions, and may face more barriers to the kind of preoperative optimization that reduces risk. Social isolation after discharge, limited help at home, and difficulty attending follow-up appointments compound the problem. These disparities represent a structural challenge, not a reason for any individual patient to delay needed surgery.

Surgical Approach and Implant Considerations

The two most common approaches to the hip joint are the anterior (from the front of the thigh) and the posterior (from the back). A study comparing these approaches for hip replacements done after a femoral neck fracture found no difference in 90-day mortality, though the anterior approach showed lower one-year mortality in that specific population.³² However, a meta-analysis found that the anterior approach carried higher overall complication rates, including more nerve injuries, wound complications, and revisions.³³ The posterior approach had a slightly higher trend toward hip dislocation, though the difference was not statistically significant. In short, neither approach is categorically safer; each has a different complication profile, and the best choice depends on the surgeon’s experience and the patient’s anatomy.

When bone cement is used to fix the implant in place, there is a rare but serious reaction called bone cement implantation syndrome, characterized by a sudden drop in blood pressure, low oxygen levels, and in the worst cases, cardiac arrest during the procedure.³⁴ Anesthesiologists are trained to watch for this, and awareness of the condition has improved outcomes. Cementless implants, which rely on the bone growing into a textured surface, avoid this specific risk entirely and are used increasingly often, particularly in younger patients.